Story thread · 2 reports / 2 sources
The Merck Product That Absolutely Demolished Wall Street's Forecasts
investors.com · 7d · first report
Merck's new injectable version of Keytruda walloped sales expectations Tuesday, packing a $200 million-plus punch vs. Wall Street's forecasts. The post The Merck Product That Absolutely Demolished Wall Street's Forecasts appeared first on Investor's Business Daily .
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.